Showing posts with label Sucheta Dalal. Show all posts
Showing posts with label Sucheta Dalal. Show all posts

Monday, January 10, 2022

Coveted Corporate Governance Award to NATCO Pharma

 6th January is a day remembered for the unfolding of 'Satyam' Fraud. But the year 2022, thanks to Money Life Foundation, the day made a mark with the former Chief Election Commissioner, T.S. Krishna Moorthy presiding over the Corporate Governance Award function and M. Damodaran, Former SEBI Chairman delivering the Key Note Address. V. Ranganathan delivered the second best Award to Thejo Engineering at Chennai on behalf of Money Life Foundation (MLF).

I had the privilege of delivering the Award to the Hyderabad-based NATCO Pharma on behalf of MLF. R. Balakrishnan, Member of the Jury had this to say at the Award Function online:

"Every country has hundreds of laws that govern behaviour. The fact that thousands of cases are pending in various courts, while thousands more are filed every day, tells us that we, as people, find it difficult to behave in a fair manner with fellow human beings and self-interest dominates most human behaviour. "

Good Corporate Governance is essentially based on Ethics and represent the trust the investors repose in the Company. I have gone through the Annual Reports of NATCO Pharma and their various issues of Spandana representing their social activities that included support extended to the society and Anganwadis in Telangana and Andhra Pradesh.

Its VC and MD, Rajiv Nannapaneni, a very unassuming person, epitomizes the company both in attire and action. 

They are not just wealth creators but are health creators, with the Active Pharmaceutical Ingredients for Oncology and Diabetology. 

This multi-layered and multi-centered Company believes that excellence is journey and not destination and has been crossing its own benchmark in performance - financial and product performance - every year in a sustainable manner.

Its corporate governance is worthy of emulation with fifty percent of the Board wearing the hat of independent directors in diverse fields of experience, guiding its destiny. 

It withstood the impact of Covid-19 pandemic with tenacity, alacrity and social responsibility. 

Its risk management and accounting practices are best in the field of pharmaceuticals. 

Its claims in the Annual Report are factual and represent the Environmentally Sustainable Governance at its best. No wonder they bagged the coveted MLF Award for 2021 Best Corporate Governance. 

Reaching the peak is one thing and reaching it every time is another thing. The latter requires much more social cohesion and singularly ethical practices. I wish them best of luck all times.